Once Daily Formulation Of Lacosamide

Patent No. EP2645997 (titled "Once Daily Formulation Of Lacosamide") was filed by UCB Pharma on Dec 1, 2011. The application was issued on Aug 10, 2022.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
GENERICS UK	May 10, 2023	ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 12, 2024
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Aug 12, 2024
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
May 6, 2024
Brief communication - Opposition proceedings
May 6, 2024
Brief communication - Opposition proceedings
May 6, 2024
Consolidated list of cited opposition documents
May 6, 2024
Decision of the Opposition Division and instruction
May 6, 2024
Decision revoking the European patent
May 6, 2024
Decision revoking the European patent
May 6, 2024
Grounds for the decision (Annex) - opposition
May 6, 2024
Means of redress
Apr 3, 2024
Notification concerning the date of oral proceedings
Apr 3, 2024
Notification concerning the date of oral proceedings
Mar 14, 2024
Brief communication - Opposition proceedings
Mar 11, 2024
(Electronic) Receipt
Mar 11, 2024
Letter accompanying subsequently filed items
Mar 11, 2024
Written submission in preparation to/during oral proceedings
Feb 1, 2024
Annex to the communication - opposition
Feb 1, 2024
Brief communication - Opposition proceedings
Feb 1, 2024
Brief communication - Opposition proceedings
Feb 1, 2024
Information concerning oral proceedings
Feb 1, 2024
Scanned annex to a communication - opposition procedure
Feb 1, 2024
Summons to attend oral proceedings
Feb 1, 2024
Summons to attend oral proceedings
Jan 29, 2024
Information about the result of oral proceedings
May 25, 2023
Communication of a notice of opposition and request to file observations
May 25, 2023
Notice of further oppositions to opponent(s)
May 17, 2023
Communication of a notice of opposition - first information to patent proprietor
May 10, 2023
(Electronic) Receipt
May 10, 2023
Citation in opposition procedure - 001
May 10, 2023
Citation in opposition procedure - 002
May 10, 2023
Citation in opposition procedure - 003
May 10, 2023
Citation in opposition procedure - 003
May 10, 2023
Citation in opposition procedure - 004
May 10, 2023
Citation in opposition procedure - 005
May 10, 2023
Citation in opposition procedure - 006
May 10, 2023
Citation in opposition procedure - 007
May 10, 2023
Citation in opposition procedure - 008
May 10, 2023
Citation in opposition procedure - 009
May 10, 2023
Citation in opposition procedure - 010
May 10, 2023
Citation in opposition procedure - 011
May 10, 2023
Citation in opposition procedure - 012
May 10, 2023
Citation in opposition procedure - 013
May 10, 2023
Consolidated list of cited opposition documents
May 10, 2023
Letter concerning fees and payments
May 10, 2023
Notice of opposition
May 10, 2023
Notice of opposition
Aug 23, 2022
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 14, 2022
Decision to grant a European patent
Jun 30, 2022
(Electronic) Receipt
Jun 30, 2022
Filing of the translations of the claims
Jun 30, 2022
French translation of claims
Jun 30, 2022
German translation of the claims
Jun 30, 2022
Letter accompanying subsequently filed items
Mar 18, 2022
Bibliographic data of the European patent application
Mar 18, 2022
Communication about intention to grant a European patent
Mar 18, 2022
Intention to grant (signatures)
Mar 18, 2022
Text intended for grant (clean copy)
Mar 18, 2022
Text intended for grant (version for approval)
Aug 7, 2020
(Electronic) Receipt
Aug 7, 2020
Amended claims with annotations
Aug 7, 2020
Amended description with annotations
Aug 7, 2020
Claims
Aug 7, 2020
Description
Aug 7, 2020
Letter accompanying subsequently filed items
Aug 7, 2020
Reply to communication from the Examining Division
Jul 14, 2020
Grant of extension of time limit (examination procedure)
Jul 9, 2020
(Electronic) Receipt
Jul 9, 2020
Request for extension of time limit to communication from the Examining Division
Mar 24, 2020
Annex to the communication
Mar 24, 2020
Communication from the Examining Division
Aug 2, 2019
(Electronic) Receipt
Aug 2, 2019
Amended claims with annotations
Aug 2, 2019
Claims
Aug 2, 2019
Letter accompanying subsequently filed items
Aug 2, 2019
Reply to communication from the Examining Division
May 28, 2019
Grant of extension of time limit (examination procedure)
May 17, 2019
(Electronic) Receipt
May 17, 2019
Request for extension of time limit to communication from the Examining Division
Jan 29, 2019
Annex to the communication
Jan 29, 2019
Communication from the Examining Division
Dec 9, 2015
(Electronic) Receipt
Dec 9, 2015
Letter accompanying subsequently filed items
Dec 9, 2015
Reply to the invitation to clarify the claims/the subject matter of the application
Nov 25, 2015
Annex to the communication
Nov 25, 2015
Invitation to indicate the basis for amendments
Aug 3, 2015
(Electronic) Receipt
Aug 3, 2015
Letter accompanying subsequently filed items
Aug 3, 2015
Matter concerning the application
Jul 21, 2015
Annex to the communication
Jul 21, 2015
Communication from the examining division with an Invitation to pay a search fee(s)
Aug 1, 2014
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Jul 26, 2014
Priority search results copy provided by EPO
Jan 28, 2014
Reminder for payment period (examination fee/designation fees)
Jan 23, 2014
Copy of the international search report
Jan 23, 2014
International publication of the international search report
Jan 14, 2014
Copy of the international preliminary report on patentability
Dec 10, 2013
Written opinion of the ISA, boxes No. I to VIII
Dec 10, 2013
Written opinion of the ISA, cover sheet
Dec 10, 2013
Written opinion of the ISA, supplemental box
Sep 11, 2013
Notification on forthcoming publication of bibliographic data
Jul 10, 2013
Communication to designated inventor
Jul 10, 2013
Communication to designated inventor
May 8, 2013
Amended claims filed after receipt of (European) search report
May 8, 2013
Request for entry into the European phase
Apr 12, 2013
Information on entry into European phase
Jun 27, 2012
Priority document (electronically transmitted)
Jun 27, 2012
Priority document (electronically transmitted)
Jun 27, 2012
Priority document (electronically transmitted)
Jun 27, 2012
Priority document (electronically transmitted)
Jun 27, 2012
Priority document (electronically transmitted)
Jun 27, 2012
Priority document (electronically transmitted)
Jun 27, 2012
Priority document (electronically transmitted)
Jun 27, 2012
Priority document (electronically transmitted)
Jun 7, 2012
Published international application - A2
Dec 1, 2011
Abstract
Dec 1, 2011
Claims
Dec 1, 2011
Description
Dec 1, 2011
Priority document (RO-procedure)
Dec 1, 2011
Priority document (RO-procedure)

EP2645997

UCB PHARMA

Application Number: EP11791442A
Filing Date: Dec 1, 2011
Status: Revoked; Sep 6, 2024
Publication Date: Aug 10, 2022
External Links: Slate, Register , Google Patents

IP Verse

Once Daily Formulation Of Lacosamide

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2645997